STAT3 and hematologic disorder: We have recently shown that somatic mutations are preferentially detectable in CD8+ cells [17] and that these mutations are especially enriched in the signal transducer and activator of transcription 3 (STAT3) gene and to lesser extent in other genes implicated in hematological malignancies [18].